HOLOGIC goes #RÖKO2023
More
ToSyMa study results phase 1: +48% detection rate for invasive breast tumors
More
SOMATEX at Master of Disaster in Essen, Germany
More
SOMATEX at the Senology Congress 2022
More
Celebrating 30 years of innovation at SOMATEX
More
Patients benefit from partnership between SOMATEX and HOLOGIC
More
SOMATEX at Master of Disaster 2021 ON-SITE and ONLINE
More
SOMATEX online at the Senology Congress 2021
More
SOMATEX participates in NCoBC the 2021
More
Tumark Vision: Highest detection rate in SenTa-Study
More